Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei

Kritsada Pruksaphon, Akarin Intaramat, Kavi Ratanabanangkoon, Joshua D Nosanchuk, Nongnuch Vanittanakom, Sirida Youngchim, Kritsada Pruksaphon, Akarin Intaramat, Kavi Ratanabanangkoon, Joshua D Nosanchuk, Nongnuch Vanittanakom, Sirida Youngchim

Abstract

Talaromyces (Penicillium) marneffei is a thermally dimorphic fungus that can cause opportunistic systemic mycoses in patients infected with the human immunodeficiency virus (HIV). It has also been reported among patients with other causes of immunodeficiency, such as systemic lupus erythematosus, cancer, organ transplanted patients receiving immunosuppressive drug and adult onset immunodeficiency syndromes. Recent studies indicate that the clinical manifestations, laboratory findings and treatment strategies of talaromycosis (penicilliosis) marneffei are different between patients with and without HIV infection. Therefore early and accurate diagnosis of talaromycosis marneffei is crucial to the proper management and treatment. Since current diagnostic methods are currently inadequate, the aim of this study was to develop an immunochromatographic test (ICT) for the detection of T. marneffei yeast antigens in urine samples. The highly T. marneffei-specific monoclonal antibody 4D1 (MAb 4D1) conjugated with gold colloid at pH 6.5 was used as signal generator. The nitrocellulose membrane was lined with T. marneffei cytoplasmic yeast antigen (TM CYA) to serve as the test line, and rabbit anti-mouse IgG was the control line. Subjecting the assembled test strip to urine samples containing T. marneffei antigen produced a visible result within 20 minutes. The sensitivity limit of the assay was 3.125μg/ml of TM CYA. The ICT was used to test urine samples from 66 patients with blood culture confirmed talaromycosis marneffei, 42 patients with other fungal or bacterial infections, and 70 normal healthy individuals from endemic area of T. marneffei. The test exhibited sensitivity, specificity and accuracy of 87.87%, 100% and 95.5%, respectively. This rapid, user-friendly test holds great promise for the serodiagnosis of T. marneffei infection.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. The ICT strip system of…
Fig 1. The ICT strip system of T. marneffei.
(a) Cartoon of the components of the T. marneffei ICT strip. (b) A schematic diagram of the ICT strips for the detection of TM CYA antigen in urine. (A: Pre-run strip, B: Positive result, C: Negative result) WP, wicking pad; AP, analytical pad; SP, sample pad; CRP, conjugate releasing pad; C, control line; T, test line.
Fig 2. MAb 4D1 similarly labels prepared…
Fig 2. MAb 4D1 similarly labels prepared T. marneffei cytoplasmic yeast antigens and proteins released into T. marneffei culture supernatants.
SDS-PAGE (A) and Western immunoblots (B) prepared with T. marneffei cytoplasmic mycelial antigen (TmM), yeast antigen (TmY) and the concentrated supernatants from day 7 (TmS1) and day 14 (TmS2) yeast cell cultures. MAb 4D1 was used in (B). The numbers on the left indicate relative molecular weights of markers (M).
Fig 3. Determination of the limit of…
Fig 3. Determination of the limit of detection (LOD) of the ICT strip.
(A) By visual inspection and (B) by UVP visionWorks LS scanner. Urine samples from healthy individuals were spiked with the indicated concentrations in μg/ml of TM CYA. NC, urine from healthy individuals as negative control; C: control line, T: test line.
Fig 4. The ICT system does not…
Fig 4. The ICT system does not detect antigens from other common fungal pathogens.
Urine samples from healthy volunteers were spiked with TM CYA (PC), TM CMA, C. albicans (Ca), C. neoformans (Cn), P. insidiosum (Pi), H. capsulatum (Hc), Penicillium sp. (Ps), A. fumigatus (Af) at 50 μg/ml each. NC, normal urine negative control; C, control line; T: test line.

References

    1. Deng ZL, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia. Review of eighteen cases and report of four more Chinese cases. Rev Infect Dis. 1988;10:640–652.
    1. Supparatpinyo K, Kwamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet. 1994; 344:110–113.
    1. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis. 1996; 23:125–130.
    1. Hien TV, Loc PP, Hoa NT, Duong NM, Quang VM, McNeil MM, et al. First cases of disseminated penicilliosis marneffei infection among patients with acquired immunodeficiency syndrome in Vietnam. Clin Infect Dis. 2001; 32:e78–80.
    1. Ranjana KH, Priyokumar K, Singh TJ, Gupta ChC, Sharmila L, Singh PN, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 2002; 45:268–271.
    1. Yuen KY, Wong SS, Tsang DN, Chau PY. Serodiagnosis of Penicillium marneffei infection. Lancet. 1994; 344:444–455.
    1. Wong SS, Siau H, Yuen KY. Penicilliosis marneffei-West meets East. J Med Microbiol. 1999; 48:973–975.
    1. Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006; 19: 95–110.
    1. Wong SS, Wong KH, Hui WT, Lee SS, Lo JY, Cao L, et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immuno- deficiency virus (HIV)-and non-HIV-infected patients. J Clin Microbiol. 2001;39: 4535–4540.
    1. Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012; 367:725–734.
    1. Kawila R, Chaiwarith R, Supparatpinyo K. Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study. BMC Infect Dis. 2013; 13: 464
    1. Chan JF, Lau SK, Yuen KY, Woo PC. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016; 5:e19
    1. Chan JF, Chan TS, Gill H, Lam FY, Trendell-Smith NJ, Sridhar S, et al. Disseminated Infections with Talaromyces marneffei in non-AIDS patients given monoclonal antibodies against CD20 and kinase inhibitors. Emerg Infect Dis. 2015; 21:1101–1106.
    1. Tse E, Leung RY, Kwong YL. Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia. Ann Hematol. 2015; 94: 165–167.
    1. Desakorn V, Smith MD, Walsh AL, Simpson AJ, Sahassananda D, Rajanuwong A, et al. Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay. J Clin Microbiol. 1999; 37:117–121.
    1. Chaiyaroj SC, Chawengkirttikul R, Sirisinha S, Watkins P, Srinoulprasert Y. Antigen detection assay for identification of Penicillium marneffei infection. J Clin Microbiol. 2003; 41:432–434.
    1. Tsui WMS, Ma KF, Tsang DN. Disseminated Penicillium marneffei infection in HIV-infected subject. Histopathology. 1992; 20:287–293.
    1. Drouhet E. Penicilliosis due to Penicillium marneffei: a new emerging systemic mycosis in AIDS patients travelling or living in southeast Asia. Review of 44 cases reported in HIV infected patients during the last 5 years compared to 44 cases of non-AIDS patients reported over 20 years. J Med Mycol. 1993; 4:195–224.
    1. Viviani AM, Tortorano AM. Penicillium marneffei In: Ajello L, Hay RJ, editors. Topley and Wilson's microbiology and microbial infections. Medical mycology. London, United Kingdom: Arnold; 1998. pp. 409–419.
    1. Desakorn V, Simpson AJ, Wuthiekanun V, Sahassananda D, Rajanuwong A, Pitisuttithum P, et al. Development and evaluation of rapid urinary antigen detection tests for diagnosis of Penicilliosis marneffei. J Clin Microbiol. 2002; 40:3179–183.
    1. Trewatcharegon S, Chaiyaroj SC, Chongtrakool P, Sirisinha S. Production and characterization of monoclonal antibodies reactive with the mycelial and yeast phases of Penicillium marneffei. Med Mycol. 2000; 38: 91–96.
    1. Arrese Estrada J, Stynen D, Van Cutsem J, Piérard-Franchimont C, Piérard GE. Immunohistochemical identification of Penicillium marneffei by monoclonal antibody. Int J Dermatol. 1992; 31:410–412.
    1. Hearn VM. Structure and function of fungal cell wall In: Jacobs PH, Nall L, editors. Fungal diseases. New York: Marcel Dekker Press; 1997.
    1. Vanittanakom N, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Curr Top Med Mycol.1997; 8:35–42.
    1. Rafferty K, Hay R, Hamilton AJ. Production of phase specific monoclonal antibodies to Penicillium marneffei and their use in diagnosis. Mycoses. 2002;
    1. Rafferty K. Penicillium marneffei: immunological response to infection and development of novel diagnostic methods. PhD Thesis. University of London, King's College London; 2004.
    1. Prakit K, Nosanchuk JD, Pruksaphon K, Vanittanakom N, Youngchim S. A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum. Eur J Clin Microbiol Infect Dis. 2016; 35:647–656.
    1. Mabey D, Peeling RW, Perkins MD. Rapid and simple point of care diagnostics for STIs. Sex Transm Infect. 2001; 77:397–398.
    1. Posthuma-Trumpie GA, Korf J, van Amerongen A. Lateral flow (immuno) assay: its strengths, weaknesses, opportunities and threats. A literature survey. Anal Bioanal Chem.2009;393:569–582.
    1. Kozel TR, Bauman SK. CrAg lateral flow assay for cryptococcosis. Expert Opin Med Diagn.2012;6:245–251.
    1. Intaramat A, Sornprachum T, Chantrathonkul B, Chaisuriya P, Lohnoo T, Yingyong W, et al. Protein A/G-based immunochromatographic test for serodiagnosis of pythiosis in human and animal subjects from Asia and Americas. Med Mycol. 2016; 54:641–647.
    1. Jeavons L, Hamilton AJ, Vanittanakom N, Ungpakorn R, Evans EG, Sirisanthana T, et al. Identification and purification of specific Penicillium marneffei antigens and their recognition by human immune sera. J Clin Microbiol. 1998; 36:949–954.
    1. Aybay C, Imir T. Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells. J Immunol Methods. 2000; 233:77–81.
    1. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem.1976; 72:248–254.
    1. Panichakul T, Chawengkirttikul R, Chaiyaroj SC, Sirisinha S. Development of a monoclonal antibody-based enzyme-linked immunosorbent assay for the diagnosis of Penicillium marneffei infection. Am J Trop Med Hyg. 2002;67:443–447.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa